Latest1 information on COVID-19
Support teaching, research, and patient care.
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
Paige Nicole Baker
+1 650-736-1252
All fields are required. *
We were not able to send your contact info at this time.